Effect of vortioxetine in subjects with major depressive and alcohol use disorders: a 6-month retrospective analysis.
Marco Di NicolaMaria PepeIsabella PanaccioneLorenzo MocciaLuigi DattoliMarzia MolinaroGabriele SaniLuigi JaniriRoger S McIntyrePublished in: CNS spectrums (2020)
Given its effectiveness on mood, cognition, and functioning, its good safety and tolerability profile, and low potential for abuse, vortioxetine could represent a valid pharmacological intervention in MDD + AUD patients as part of an integrated therapeutic-rehabilitation program.